Clinical and Translational Gastroenterology

Aims & Scope

Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a peer-reviewed open access online journal dedicated to innovative clinical work in the field of gastroenterology and hepatology.

CTG hopes to fulfill an unmet need for clinicians and scientists by welcoming novel cohort studies, early-phase clinical trials, qualitative and quantitative epidemiologic research, hypothesis-generating research, studies of novel mechanisms and methodologies including public health interventions, and integration of approaches across organs and disciplines.

CTG also welcomes hypothesis-generating small studies, methods papers, and translational research with clear applications to human physiology or disease.

Colon and small bowel Endoscopy and novel diagnostics Esophagus Functional GI disorders Immunology of the GI tract Microbiology of the GI tract Inflammatory bowel disease Pancreas and biliary tract Liver Pathology Pediatrics Preventative medicine Nutrition/obesity Stomach.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Plagiarism url
• Preservation url
• Apc url

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Human Intestinal Barrier Function in Health and Disease

  Citation: 667

  Authors: Julia, Jerry, Patrice D, Clara L, Tom, Annick, Jacqueline, Freddy, Robert-Jan

• Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

  Citation: 562

  Authors: Giulia, Bindia, Narula, Jean-Frederic

• A Primer on Effectiveness and Efficacy Trials

  Citation: 513

  Authors: Amit G, Peter D R, Akbar K

• Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis

  Citation: 280

  Authors: Aldo J, Andres, Judith, Vickie E, Michael B, Jack X Q, Crystal, Nina, Robert P

• Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location

  Citation: 242

  Authors: Kosuke, Yin, Andrew T, Zhi Rong, Jonathan A, Yohei, Yan, Mingyang, Annacarolina, Mancang, Wanwan, Tsuyoshi, Keisuke, Akiko, Li, Aleksandar D, Marios, Susan, Caitlin A, Danny A, Hideo, Levi A, Jeffrey A, Wendy S, Curtis, Matthew, Edward L, Charles S, Reiko, Shuji

• A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

  Citation: 206

  Authors: R.K., E., E., J., P.R., P., I.O., A., Y., I., M., S., K.A., G.

• The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

  Citation: 190

  Authors: Parth J, Luis A, David A

• Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome

  Citation: 181

  Authors: Lauren K, Stephen J D, Ken, Simon M, Georg, Ulrich-Frank, Benjamin, Nader N, Palle B

• KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma

  Citation: 173

  Authors: Barbara, Fabrice, Camille, Eric, Marc, Pascal, Janick, Rosine, Pierre, Louis

• Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects

  Citation: 160

  Authors: K EC, G J, E., A V, R S, S D, S., L., P. W., V., M., F., N. A. W., H J, J A, G M, M J, M T, E M, Willems K., F., A K, M.